Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document C2016/351/04

Prior notification of a concentration (Case M.8174 — Talanx/Aberdeen/Escala Vila Franca/PNH Parque) — Candidate case for simplified procedure (Text with EEA relevance)

OJ C 351, 27.9.2016, p. 4–4 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

27.9.2016   

EN

Official Journal of the European Union

C 351/4


Prior notification of a concentration

(Case M.8174 — Talanx/Aberdeen/Escala Vila Franca/PNH Parque)

Candidate case for simplified procedure

(Text with EEA relevance)

(2016/C 351/04)

1.

On 21 September 2016, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Talanx AG (‘Talanx’, Germany) and Aberdeen Infrastructure (Holdco) BV (‘Aberdeen’, The Netherlands) acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the undertakings Escala Vila Franca — Sociedade Gestora do Edifício, SA (‘Escala Vila Franca’, Portugal) and PNH — Parque do Novo Hospital, SA (‘PNH Parque’, Portugal) by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Talanx: operation in primary insurance and reinsurance in about 150 countries,

—   for Aberdeen: investment fund engaged in the management of infrastructure equity investments active in infrastructure projects in the sectors of transport, health, accommodation, waste and rail,

—   for Escala Vila Franca: concession holder responsible for the design, project, construction, management and operation, conservation and maintenance of the Vila Franca Hospital’s Infrastructure for a period of 30 years,

—   for PNH Parque: subcontractor company responsible for the management of the parking space of the Vila Franca Hospital.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.8174 — Talanx/Aberdeen/Escala Vila Franca/PNH Parque, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.


Top